Download PDF
CC BY-NC-ND 4.0 · South Asian J Cancer
DOI: 10.1055/s-0044-1789272
Original Article

Cancer Unveiling: A Profile of Incidence and Trends in Bam City, Southeast Iran

Maryam Jalali 
1   Colorectal Research Center, Mohammad Rasoolullah (PBUH) Research Tower, Shiraz University of Medical Sciences, Shiraz, Iran
,
Navid Reza GHasemi
2   Subscriber Affairs Department, Gas Company, Bam, Iran
,
Sajad KHosravi
3   Non-Communicable Diseases Research Center, Bam University of Medical Sciences, Bam, Kerman, Iran
,
Mahnaz Hasani
4   Health Department, Specialized Group for Prevention and Fight Against Noncommunicable Diseases, Bam University of Medical Sciences, Bam, Iran
,
Samane Nematolahi
3   Non-Communicable Diseases Research Center, Bam University of Medical Sciences, Bam, Kerman, Iran
,
Najaf Zare
5   Infertility Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Abstract

Zoom Image
Samane Nematolahi

Background Cancer is one of the leading causes of mortality and morbidity worldwide. According to the report from the Iranian Ministry of Health, cancer ranks as the third most common cause of death in Iran. Consequently, acquiring information about cancer statistics and their trends is crucial for cancer prevention and control. In this study, we examined the trends and epidemiology of cancer in Bam City, Iran, from 2014 to 2019.

Material and Methods This cross-sectional study was conducted using cancer registry data spanning from 2014 to 2019 in Bam, located in Kerman Province. Common cancers were determined based on the reported number of cancer cases and age-standardized rates. Data analysis was performed using SPSS (version 22) and GraphPad Prism (version 9).

Results In this study, we examined 1,290 cases of cancer registered in Bam City, Kerman Province, from 2014 to 2019. Of our study population, 42.8% (552 cases) were women. The sex ratio (male to female) for all cancers during the 6-year study period was 1.34. The highest number of cancer cases among men occurred in 2016, while among women, it was in 2017. The age-standardized incidence rate did not display a clear increasing or decreasing trend; instead, we observed fluctuations over the 6-year period for both sexes. Notably, the age-standardized incidence rate trend for males consistently remained higher than that for females.

Conclusion Fluctuations of the trend in our study can be attributed to reasons such as referral of cases to other cities with better medical facilities and weakness in the cancer registration system of deprived areas such as Bam. Nevertheless, to reduce the burden of cancer, each individual should be aware of the most preventable risk factors, such as an unhealthy lifestyle and occupational exposure. To achieve this goal, the government should prioritize improving the accuracy and completeness of cancer registry centers.

Keywords

cancer - time trends - Bam - age-standardized rate

Availability of Data and Materials

The data that support the findings of this study are available from the corresponding author upon reasonable request.


Consent for Publication

Informed written consent was obtained from each of the patients before enrollment.


Authors' Contributions

Study concept and design were developed by S.N. and M.J. Analysis and interpretation of data was done by S.N. Drafting of the manuscript was done by M.J., S.N., S.KH., and N.R.GH. Critical revision of the manuscript for important intellectual content was done by S.N., M.J., N.R.GH, and S.KH. Statistical analysis was done by S.N. and MJ. Acquisition of the data was by S.KH. and M.H. All the authors have read and approved the final manuscript.


Ethical Approval and Consent to Participate

The study was approved by the ethics committee and confirmation was taken from Bam University of Medical Sciences (ethical code: IR.MUBAM.REC.1402.041). Confidentiality of their personal data of the participants was emphasized.




Publication History

Received: 09 March 2024

Accepted: 26 July 2024

Article published online:
06 September 2024

© 2024. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Vos T, Abajobir AA, Abate KH. et al; GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017; 390 (10100): 1211-1259
    CrossrefPubMedGoogle Scholar
  • 2 World Health Organization. Global Status Report on Noncommunicable Diseases 2010. Geneva: World Health Organization; 2011
    Google Scholar
  • 3 Ferlay J, Soerjomataram I, Dikshit R. et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136 (05) E359-E386
    CrossrefPubMedGoogle Scholar
  • 4 Naghavi M. Death Report from 10 Provinces in Iran. . Tehran: Ministry of Health; 2000
    Google Scholar
  • 5 Ali Mohagheghi M, Mosavi-Jarrahi A. Review of cancer registration and cancer data in Iran, a historical prospect. Asian Pac J Cancer Prev 2010; 11 (04) 1155-1157
    PubMedGoogle Scholar
  • 6 Fateh M, Emamian MH. Cancer incidence and trend analysis in Shahroud, Iran, 2000 - 2010. Iran J Cancer Prev 2013; 6 (02) 85-94
    PubMedGoogle Scholar
  • 7 Amoori N, Mirzaei M, Cheraghi M. Incidence of cancers in Kuzestan Province of Iran: trend from 2004 to 2008. Asian Pac J Cancer Prev 2014; 15 (19) 8345-8349
    CrossrefPubMedGoogle Scholar
  • 8 Vakili M, Pirdehghan A, Adimi M, Sadeghian M, Akhondi M. Epidemiology and trend of cancer in Yazd, a central province of Iran, 2005-2009. J Res Health Sci 2014; 14 (03) 210-213
    PubMedGoogle Scholar
  • 9 Rahimi F, Heidari MJH, Journal D. Time trend analysis of stomach cancer incidence in the west of Iran. Health Development J 2012; 1 (02) 100-111
    Google Scholar
  • 10 Masoompour SM, Yarmohammadi H, Rezaianzadeh A, Lankarani KB. Cancer incidence in southern Iran, 1998-2002: results of population-based cancer registry. Cancer Epidemiol 2011; 35 (05) e42-e47
    CrossrefPubMedGoogle Scholar
  • 11 Sobin LH. Cancer in Afghanistan. Cancer 1969; 23 (03) 678-688
    CrossrefPubMedGoogle Scholar
  • 12 Mohebbi E, Nahvijou A, Hadji M. et al. Iran Cancer Statistics in 2012 and projection of cancer incidence by 2035. Basic Clinical Cancer Res 2017; 9 (03) 3-22
    Google Scholar
  • 13 Norouzi Nejad F, Ramezani Daryasar R, Ghafari FJ. Epidemiology of cancer in Mazandaran Province 2006. J Mazandaran Univ Med Sci 2009; 19 (72) 61-65
    Google Scholar
  • 14 Roshandel G, Sadjadi A, Aarabi M. et al. Cancer incidence in Golestan Province: report of an ongoing population-based cancer registry in Iran between 2004 and 2008. Arch Iran Med 2012; 15 (04) 196-200
    PubMedGoogle Scholar
  • 15 Rahimi F, Heidari M. Time trend analysis of stomach cancer incidence in the west of Iran. Health Development J 2012; 1 (02) 100-111
    Google Scholar
  • 16 Boyle P, Levin B. World Cancer Report 2008. Lyon, France: International Agency for Research on Cancer (IARC) Press; 2008
    Google Scholar
  • 17 Keyghobadi N, Rafiemanesh H, Mohammadian-Hafshejani A, Enayatrad M, Salehiniya H. Epidemiology and trend of cancers in the province of Kerman: southeast of Iran. Asian Pac J Cancer Prev 2015; 16 (04) 1409-1413
    CrossrefPubMedGoogle Scholar
  • 18 Assi HA, Khoury KE, Dbouk H, Khalil LE, Mouhieddine TH, El Saghir NS. Epidemiology and prognosis of breast cancer in young women. J Thorac Dis 2013; 5 (Suppl. 01) S2-S8
    CrossrefPubMedGoogle Scholar
  • 19 Barnard ME, Boeke CE, Tamimi RM. Established breast cancer risk factors and risk of intrinsic tumor subtypes. Biochim Biophys Acta 2015; 1856 (01) 73-85
    PubMedGoogle Scholar
  • 20 Nematolahi S, Rezaianzadeh A, Zare N, Akrami M, Tahmasebi S. Prognostic factors of breast cancer survival in the Islamic Republic of Iran: an additive empirical Bayesian approach. East Mediterr Health J 2018; 23 (11) 721-728
    CrossrefPubMedGoogle Scholar
  • 21 Nematolahi S, Ayatollahi SMT. A comparison of breast cancer survival among young, middle-aged, and elderly patients in southern Iran using Cox and empirical Bayesian additive hazard models. Epidemiol Health 2017; 39: e2017043
    CrossrefPubMedGoogle Scholar
  • 22 Farahmand M, Almasi-Hashiani A. Epidemiology of bladder cancers in Fars Province, Southern Iran (2003–2008). J Kerman Univ Med Sci 2013; 20 (04) 387-394
    Google Scholar
  • 23 Danaei M, Haghdoost A, Momeni M. An epidemiological review of common cancers in Iran; a review article. Iran J Blood Cancer 2019; 11 (03) 77-84
    Google Scholar
  • 24 Huang J, Chan SC, Lok V. et al; Non-communicable Disease Global Health Research Group, Association of Pacific Rim Universities. The epidemiological landscape of multiple myeloma: a global cancer registry estimate of disease burden, risk factors, and temporal trends. Lancet Haematol 2022; 9 (09) e670-e677
    CrossrefPubMedGoogle Scholar
  • 25 Clapp RW, Jacobs MM, Loechler EL. Environmental and occupational causes of cancer: new evidence 2005-2007. Rev Environ Health 2008; 23 (01) 1-37
    CrossrefPubMedGoogle Scholar
  • 26 Shah SC, Kayamba V, Peek Jr RM, Heimburger D. Cancer control in low-and middle-income countries: is it time to consider screening?. J Glob Oncol 2019; 5: 1-8
    CrossrefPubMedGoogle Scholar
  • 27 Keramatinia A, Hassanipour S, Nazarzadeh M. et al. Correlation between nitrogen dioxide as an air pollution indicator and breast cancer: a systematic review and meta-analysis. Asian Pac J Cancer Prev 2016; 17 (01) 419-424
    CrossrefPubMedGoogle Scholar
  • 28 Malhotra J, Malvezzi M, Negri E, La Vecchia C, Boffetta P. Risk factors for lung cancer worldwide. Eur Respir J 2016; 48 (03) 889-902
    CrossrefPubMedGoogle Scholar
  • 29 Domper Arnal MJ, Ferrández Arenas Á, Lanas Arbeloa Á. Esophageal cancer: risk factors, screening and endoscopic treatment in Western and Eastern countries. World J Gastroenterol 2015; 21 (26) 7933-7943
    CrossrefPubMedGoogle Scholar
  • 30 Ziaaddini H. The prevalence of smoking and related factors in Kerman high school students. J Fundamentals Mental Health 2008; 10 (39) 239-245
    Google Scholar
  • 31 Rafiemanesh H, Rajaei-Behbahani N, Khani Y. et al. Incidence trend and epidemiology of common cancers in the center of Iran. Glob J Health Sci 2015; 8 (03) 146-155
    CrossrefPubMedGoogle Scholar
  • 32 Linet MS, Ries LA, Smith MA, Tarone RE, Devesa SS. Cancer surveillance series: recent trends in childhood cancer incidence and mortality in the United States. J Natl Cancer Inst 1999; 91 (12) 1051-1058
    CrossrefPubMedGoogle Scholar
  • 33 Wang Z, Guo E, Yang B. et al. Trends and age-period-cohort effects on mortality of the three major gynecologic cancers in China from 1990 to 2019: cervical, ovarian and uterine cancer. Gynecol Oncol 2021; 163 (02) 358-363
    CrossrefPubMedGoogle Scholar